Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
Unlearn
  • News

Unlearn Appoints Krates Ng as Chief Technology Officer

  • The Pharma Data
  • April 9, 2025

Unlearn Appoints Krates Ng as Chief Technology Officer to Lead Next Phase of Technological and Operational Expansion Unlearn®, a pioneer in developing artificial intelligence solutions to optimize clinical trials, has…

Read MoreUnlearn Appoints Krates Ng as Chief Technology Officer
Kivu
  • Press Releases

IBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels

  • The Pharma Data
  • April 9, 2025

IBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels IBL International GmbH, a Tecan Group company renowned for its expertise in specialty diagnostics, has officially announced a strategic partnership…

Read MoreIBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels
Cancer
  • Regulatory

New Cancer Cell Study Backs CEL-SCI’s Early Approval Bid for Multikine in Head & Neck Cancer

  • The Pharma Data
  • April 9, 2025

New Cancer Cell Study Backs CEL-SCI’s Early Approval Bid for Multikine in Head & Neck Cancer CEL-SCI Corporation (NYSE American: CVM), a clinical-stage immunotherapy company developing innovative treatments for cancer…

Read MoreNew Cancer Cell Study Backs CEL-SCI’s Early Approval Bid for Multikine in Head & Neck Cancer
Agitated Solutions
  • RegulatoryResearch

Agitated Solutions Gets FDA IND Nod for Phase 3 Contrast Agent Trial

  • The Pharma Data
  • April 9, 2025

Agitated Solutions Gets FDA IND Nod for Phase 3 Contrast Agent Trial Agitated Solutions, Incorporated (ASI), a medical technology company focused on cardiovascular imaging innovation, announced a pivotal regulatory milestone…

Read MoreAgitated Solutions Gets FDA IND Nod for Phase 3 Contrast Agent Trial
Guardian Pharmacy
  • News

Guardian Pharmacy Services Expands LTC Reach with Naples Pharmacy Acquisition

  • The Pharma Data
  • April 9, 2025

Guardian Pharmacy Services Expands LTC Reach with Naples Pharmacy Acquisition Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the largest and most forward-thinking long-term care (LTC) pharmacy providers in the…

Read MoreGuardian Pharmacy Services Expands LTC Reach with Naples Pharmacy Acquisition
Alpenglow
  • Press Releases

Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer

  • The Pharma Data
  • April 9, 2025

Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer Alpenglow Biosciences, a leading innovator in 3D spatial biology and digital pathology, is pleased to announce…

Read MoreAlpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer
Opdivo
  • Regulatory

FDA Approves Opdivo Plus Yervoy® for Untreated MSI-H or dMMR Metastatic Colorectal Cancer

  • The Pharma Data
  • April 9, 2025

FDA Approves Opdivo Plus Yervoy® for Untreated MSI-H or dMMR Metastatic Colorectal Cancer Bristol Myers Squibb today announced a major milestone in cancer immunotherapy with the U.S. Food and Drug…

Read MoreFDA Approves Opdivo Plus Yervoy® for Untreated MSI-H or dMMR Metastatic Colorectal Cancer
Ethris
  • News

Ethris and Lonza Partner to Advance Spray-Dried mRNA Vaccines Targeting Respiratory Illnesses

  • The Pharma Data
  • April 8, 2025

Ethris and Lonza Partner to Advance Spray-Dried mRNA Vaccines Targeting Respiratory Illnesses In a major step toward transforming the landscape of vaccine development and delivery, Ethris, a clinical-stage biotechnology company…

Read MoreEthris and Lonza Partner to Advance Spray-Dried mRNA Vaccines Targeting Respiratory Illnesses
Avenacy
  • RegulatoryNews

Avenacy Introduces Propofol Injectable Emulsion, USP to the U.S. Market

  • The Pharma Data
  • April 8, 2025

Avenacy Introduces Propofol Injectable Emulsion, USP to the U.S. Market Avenacy Launches FDA-Approved Propofol Injectable Emulsion, USP in the United States: A Milestone in Critical Care and Anesthesia Access Avenacy,…

Read MoreAvenacy Introduces Propofol Injectable Emulsion, USP to the U.S. Market
Sail Biomedicines
  • Press Releases

Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors

  • The Pharma Data
  • April 8, 2025

Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors Sail Biomedicines, Inc., a pioneering biotechnology company at the forefront of programmable RNA-based medicines and a Flagship Pioneering-founded enterprise,…

Read MoreSail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors
Corcept
  • Research

Corcept Begins Trial of Relacorilant Combo in Resistant Ovarian Cancer

  • The Pharma Data
  • April 8, 2025

Corcept Begins Trial of Relacorilant Combo in Resistant Ovarian Cancer Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on the discovery and development of innovative therapies that modulate…

Read MoreCorcept Begins Trial of Relacorilant Combo in Resistant Ovarian Cancer
Kashiv BioSciences
  • Business

Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management

  • The Pharma Data
  • April 8, 2025

Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management Kashiv BioSciences, LLC (“Kashiv” or “the Company”), a fully integrated and innovation-driven biopharmaceutical company, announced today the successful…

Read MoreKashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • WuXi Biologics Completes Structure of Chengdu Microbial Manufacturing Facility as Key Equipment Arrives
  • Johnson & Johnson Initiates Landmark Head-to-Head Trial of Pulsed Field Ablation in Persistent Atrial Fibrillation
  • Dental Care Alliance Unveils Strategic Deal to Reinforce Financial Position and Drive Long-Term Growth
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.